Intrahepatic cholestasis of pregnancy
ICD-10 O26.64 is a billable code used to indicate a diagnosis of intrahepatic cholestasis of pregnancy.
Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that occurs during pregnancy, characterized by intense itching and elevated bile acids in the maternal bloodstream. It typically arises in the third trimester and is associated with increased risks for both the mother and fetus, including preterm birth and fetal distress. The exact etiology remains unclear, but it is believed to involve hormonal changes and genetic predisposition. Maternal symptoms often include pruritus, particularly on the palms and soles, and may be accompanied by jaundice in severe cases. Diagnosis is confirmed through elevated serum bile acids and liver function tests. Management focuses on symptom relief and monitoring fetal well-being, with potential interventions including ursodeoxycholic acid to reduce bile acid levels and improve maternal symptoms. Close monitoring of fetal heart rate and gestational age is essential to mitigate risks associated with ICP, making it a significant condition in obstetric care.
Detailed documentation of maternal symptoms, lab results, and treatment plans is essential for accurate coding.
Patients presenting with itching and elevated bile acids, requiring monitoring and potential intervention.
Consideration of the timing of symptoms in relation to gestational age and potential impacts on delivery.
Thorough documentation of high-risk factors, including maternal history and fetal assessments.
Management of high-risk pregnancies with ICP, including close monitoring and potential early delivery.
Coordination with obstetricians for comprehensive care and documentation of multidisciplinary approaches.
Used for follow-up visits for monitoring ICP and managing symptoms.
Documentation must include assessment of symptoms, lab results, and treatment plans.
Obstetricians should ensure comprehensive documentation of maternal and fetal assessments.
Common symptoms include intense itching, particularly on the palms and soles, and in some cases, jaundice. These symptoms typically arise in the third trimester and can significantly impact maternal comfort and fetal health.
